The seventh round of negotiations for the Transatlantic Trade and Investment Partnership (TTIP) took place between 29 September and 3 October in Chevy Chase, Maryland. As expected, negotiations were largely focused on regulatory issues. Discussions also covered energy, intellectual property, small and medium sized enterprises (SMEs) and services.<\/p>
<\/p>
<\/p>
<\/p>
There was good technical progress, particularly on regulatory coherence, for example in the automotive and pharmaceutical sectors. This progress is crucial and prepares the ground for an ambitious and comprehensive agreement.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4070", "label" : {"_value" : "Biography information for Matt Hancock"} } , "answeringMemberConstituency" : {"_value" : "West Suffolk"} , "answeringMemberPrinted" : {"_value" : "Matthew Hancock"} , "dateOfAnswer" : {"_value" : "2014-11-06", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-06T13:58:22.816165Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "26"} , "answeringDeptShortName" : {"_value" : "Business, Innovation and Skills"} , "answeringDeptSortName" : {"_value" : "Business, Innovation and Skills"} , "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Transatlantic Trade and Investment Partnership"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Innovation and Skills, what progress he has made on the recent round of discussions on the Transatlantic Trade and Investment Partnership.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3910", "label" : {"_value" : "Biography information for Guto Bebb"} } , "tablingMemberConstituency" : {"_value" : "Aberconwy"} , "tablingMemberPrinted" : [{"_value" : "Guto Bebb"} ], "uin" : "211894"} , {"_about" : "http://data.parliament.uk/resources/100878", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/100878/answer", "answerText" : {"_value" : "
More than 10% of women experience perinatal mental health problems or mental illness (i.e. during pregnancy or in the first postnatal year) and that is why improving diagnosis and services for women with perinatal mental health problems is one of the Department\u2019s key objectives for maternity care.<\/p>
<\/p>
<\/p>
<\/p>
Health Education England is working with partners to ensure that pre and post registration training in perinatal mental health is available to enable specialist staff to be available to every birthing unit by 2017.<\/p>
<\/p>
<\/p>
<\/p>
The ICD-10 classification system categorises conditions experienced by women during pregnancy and childbirth under \u2018mental and behavioural disorders in pregnancy, childbirth and the puerperium\u2019. There are eight ICD-10 codes for perinatal mental health diagnoses. F53.0 is the code assigned to postnatal depression.<\/p>
<\/p>
<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"} } , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"} , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"} , "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-10-29T15:10:26.3121789Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pregnancy: Mental Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 23 October 2014 to Question 211152, which terms used to describe mental health conditions experienced by women during pregnancy and in the first year after their child is born are classifiable within the ICD-10 (International Classification of Diseases) classification system used to identify diagnoses in the Hospital Episode Statistics database.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"} } , "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"} , "tablingMemberPrinted" : [{"_value" : "Luciana Berger"} ], "uin" : "211869"} , {"_about" : "http://data.parliament.uk/resources/100879", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/100879/answer", "answerText" : {"_value" : "
The Senior Responsible Officer at NHS England for perinatal mental health is Jane Cummings, the Chief Nursing Officer.<\/p>
<\/p>
<\/p>
<\/p>
NHS England is responsible for commissioning Specialised Perinatal Mental Health Services (In-patient Mother and Baby Units) nationally. Non-specialised services are commissioned by local clinical commissioning groups.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"} } , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"} , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"} , "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-10-29T14:28:27.8616709Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pregnancy: Mental Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 24 October 2014 to Question 211354, which official at NHS England has the lead responsibility for perinatal mental health services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"} } , "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"} , "tablingMemberPrinted" : [{"_value" : "Luciana Berger"} ], "uin" : "211870"} , {"_about" : "http://data.parliament.uk/resources/100886", "AnsweringBody" : [{"_value" : "Cabinet Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/100886/answer", "answerText" : {"_value" : "
The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1556", "label" : {"_value" : "Biography information for Mr Rob Wilson"} } , "answeringMemberConstituency" : {"_value" : "Reading East"} , "answeringMemberPrinted" : {"_value" : "Mr Rob Wilson"} , "attachment" : {"_about" : "http://data.parliament.uk/resources/100886/answer/attachment/1", "fileName" : {"_value" : "PQ 211917 ONS 369.pdf"} , "title" : "ONS Letter to Member - Death from Asthma"} , "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-10-29T16:57:49.537Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "53"} , "answeringDeptShortName" : {"_value" : "Cabinet Office"} , "answeringDeptSortName" : {"_value" : "Cabinet Office"} , "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Asthma"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Minister for the Cabinet Office, how many people (a) under and (b) over the age of 18 died as a result of asthma in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"} } , "tablingMemberConstituency" : {"_value" : "Leicester West"} , "tablingMemberPrinted" : [{"_value" : "Liz Kendall"} ], "uin" : "211917"} , {"_about" : "http://data.parliament.uk/resources/100887", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/100887/answer", "answerText" : {"_value" : "
The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p>
<\/p>
<\/p>
<\/p>
£ million<\/em><\/p> <\/p> 2009-10<\/p><\/td> 2010-11<\/p><\/td> 2011-12<\/p><\/td> 2012-13<\/p><\/td> 2013-14<\/p><\/td><\/tr> Asthma<\/p><\/td><\/tr> Medical Research Council<\/p><\/td> Other Research Councils and Innovate UK<\/p><\/td> 0.0<\/p><\/td> 0.1<\/p><\/td> 0.3<\/p><\/td> 1.5<\/p><\/td> 0.8<\/p><\/td><\/tr> National Institute for Health Research<\/p><\/td> 2.6<\/p><\/td> 3.4<\/p><\/td> 2.4<\/p><\/td> 3.4<\/p><\/td> 3.8<\/p><\/td><\/tr> Total<\/p><\/td> Motor Neurone Research<\/p><\/td><\/tr> Medical Research Council<\/p><\/td> 7.0<\/p><\/td> 7.5<\/p><\/td> 4.2<\/p><\/td> 4.1<\/p><\/td> 3.6<\/p><\/td><\/tr> Other Research Councils and Innovate UK<\/p><\/td> 0.2<\/p><\/td> 0.2<\/p><\/td> 0.4<\/p><\/td> 0.7<\/p><\/td> 1.0<\/p><\/td><\/tr> National Institute for Health Research<\/p><\/td> 0.1<\/p><\/td> 0.1<\/p><\/td> 0.4<\/p><\/td> 0.7<\/p><\/td> 0.5<\/p><\/td><\/tr> Total<\/p><\/td> 7.3<\/p><\/td> 7.8<\/p><\/td> 5.0<\/p><\/td> 5.5<\/p><\/td> 5.1<\/p><\/td><\/tr> Osteoporosis<\/p><\/td><\/tr> Medical Research Council<\/p><\/td> 6.2<\/p><\/td> 5.4<\/p><\/td> 5.1<\/p><\/td> 4.6<\/p><\/td> 5.9<\/p><\/td><\/tr> Other Research Councils and Innovate UK<\/p><\/td> 0.0<\/p><\/td> 0.0<\/p><\/td> 0.1<\/p><\/td> 0.4<\/p><\/td> 1.0<\/p><\/td><\/tr> National Institute for Health Research<\/p><\/td> 0.3<\/p><\/td> 0.7<\/p><\/td> 0.8<\/p><\/td> 1.3<\/p><\/td> 1.8<\/p><\/td><\/tr> Total<\/p><\/td> 6.5<\/p><\/td> 6.1<\/p><\/td> 6.0<\/p><\/td> 6.3<\/p><\/td> 8.7<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p> <\/p> <\/p> <\/p> Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p> <\/p> <\/p> <\/p> Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100887/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
}
, "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:28.3318918Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Asthma"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how much public funding was allocated to research into asthma in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
}
, "tablingMemberConstituency" : {"_value" : "Leicester West"}
, "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
], "uin" : "211918"}
, {"_about" : "http://data.parliament.uk/resources/100888", "AnsweringBody" : [{"_value" : "Cabinet Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100888/answer", "answerText" : {"_value" : " The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1556", "label" : {"_value" : "Biography information for Mr Rob Wilson"}
}
, "answeringMemberConstituency" : {"_value" : "Reading East"}
, "answeringMemberPrinted" : {"_value" : "Mr Rob Wilson"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/100888/answer/attachment/1", "fileName" : {"_value" : "PQ 211893 ONS 370.pdf"}
, "title" : "ONS Letter to Member - Death from Skin Cancer"}
, "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-29T16:56:43.7510918Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "53"}
, "answeringDeptShortName" : {"_value" : "Cabinet Office"}
, "answeringDeptSortName" : {"_value" : "Cabinet Office"}
, "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Skin Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Minister for the Cabinet Office, how many people have died as a result of (a) malignant melanoma and (b) other forms of skin cancer in England and Wales in the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1387", "label" : {"_value" : "Biography information for Lord Mann"}
}
, "tablingMemberConstituency" : {"_value" : "Bassetlaw"}
, "tablingMemberPrinted" : [{"_value" : "John Mann"}
], "uin" : "211893"}
, {"_about" : "http://data.parliament.uk/resources/100889", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100889/answer", "answerText" : {"_value" : " National Institute for Health and Care Excellence\u2019s independent advisory committee recommends new indicators or changes to existing indicators. NHS Employers, on behalf of NHS England, then negotiate with the General Practitioners Committee of the British Medical Association on which of the published indicators should be applied nationally and what the financial value and payment thresholds for those indicators should be.<\/p> <\/p> <\/p> <\/p> There are currently four indicators within the Quality and Outcomes Framework (QOF) that relate to cervical screening. These have had a positive impact upon increasing the participation in the screening programme in the past years. In April this year, one indicator on cervical screening: The contractor ensures there is a system for informing all women of the results of cervical screening tests<\/em> was retired, as part of efforts to reduce QOF by more than a third to free up space for GPs to provide more personalised care. Indicators were retired where they were duplicating other existing incentives, were of low clinical value, were unnecessarily prescriptive or were already embedded in clinical practice. The removal of the indicators will reduce bureaucracy, unnecessary patient testing and unnecessary frequency of patient recall and recording.<\/p> <\/p> <\/p> <\/p> There are two indicators that are relevant for all cancers. Indicators on Breast and Bowel Cancer are not currently within the QOF; however Public Health England will continue to explore with NICE whether these conditions should be included.<\/p> <\/p> <\/p> For 2015-16, there will not be any alterations to the cervical screening or cancer indicators, nor any new indicators for cancer, including breast and bowel cancer.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "211899"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-29T17:20:41.4400608Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what his policy is on the inclusion of (a) breast and (b) bowel cancer indicators in the Quality and Outcomes Framework.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1390", "label" : {"_value" : "Biography information for Mr John Baron"}
}
, "tablingMemberConstituency" : {"_value" : "Basildon and Billericay"}
, "tablingMemberPrinted" : [{"_value" : "Mr John Baron"}
], "uin" : "211903"}
, {"_about" : "http://data.parliament.uk/resources/100890", "AnsweringBody" : [{"_value" : "Department for Education"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100890/answer", "answerText" : {"_value" : " Schools can choose whether to cover this topic as part of their curriculum. The non-statutory framework for Personal, Social, Health and Economic (PSHE) education produced by the PSHE Association provides a context for teaching young people about emergency lifesaving skills (ELS) and resuscitation.<\/p> <\/p> At primary level, pupils can learn about basic emergency procedures and where to get help, and at secondary level they can develop the skills to cope with emergency situations that require basic first aid procedures, including resuscitation techniques.<\/p> <\/p> The Department for Education is encouraging schools to purchase defibrillators as part of their first aid equipment, and is currently working in partnership with the Department of Health and stakeholders to identify a supplier of defibrillators at a competitive price. An announcement is expected in early December.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/111", "label" : {"_value" : "Biography information for Nick Gibb"}
}
, "answeringMemberConstituency" : {"_value" : "Bognor Regis and Littlehampton"}
, "answeringMemberPrinted" : {"_value" : "Mr Nick Gibb"}
, "dateOfAnswer" : {"_value" : "2014-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-03T14:59:29.942973Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "60"}
, "answeringDeptShortName" : {"_value" : "Education"}
, "answeringDeptSortName" : {"_value" : "Education"}
, "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "First Aid"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Education, if her Department will take steps to ensure that more young people are trained in cardiopulmonary resuscitation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3910", "label" : {"_value" : "Biography information for Guto Bebb"}
}
, "tablingMemberConstituency" : {"_value" : "Aberconwy"}
, "tablingMemberPrinted" : [{"_value" : "Guto Bebb"}
], "uin" : "211897"}
, {"_about" : "http://data.parliament.uk/resources/100891", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100891/answer", "answerText" : {"_value" : " The National Institute for Health and Care Excellence (NICE) has published cancer service guidance which outlines how healthcare services for people with skin tumours, including melanoma, should be organised. In May 2010 NICE issued a partial update to the guidance, including new recommendations on the management of low-risk basal cell carcinomas in the community.<\/p> <\/p> <\/p> <\/p> NICE is currently developing a clinical guideline on the assessment and management of melanoma, which is currently planned for publication in July 2015.<\/p> <\/p> Further details of NICE\u2019s guidance on skin cancer are available at:<\/p> <\/p> <\/p> <\/p> <\/td> 22.2 <\/del>6.6<\/ins><\/p><\/td>17.5 <\/del>5.3<\/ins><\/p><\/td>17.2<\/del> 4.5<\/ins><\/p><\/td>19.4<\/del> 3.6<\/ins><\/p><\/td>18.8<\/del> 5.4<\/ins><\/p><\/td><\/tr>24.8<\/del> 9.2<\/ins><\/p><\/td>21.0<\/del> 8.8<\/ins><\/p><\/td>19.9<\/del> 7.2<\/ins><\/p><\/td>24.3 <\/del>8.5<\/ins><\/p><\/td>23.4<\/del> 10.0<\/ins><\/p><\/td><\/tr>